Published in Surg Gynecol Obstet on October 01, 1985
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg (2005) 4.13
Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg (1990) 3.25
Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg (2007) 2.53
Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg (2003) 2.21
Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients. Ann Surg (2007) 2.16
Bloodless liver resection using the monopolar floating ball plus ligasure diathermy: preliminary results of 16 liver resections. World J Surg (2004) 2.04
Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg (1995) 1.81
Impact of intraoperative ultrasonography in laparoscopic liver surgery. Surg Endosc (2006) 1.80
Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg (1996) 1.73
Meta-analysis of anatomic resection versus nonanatomic resection for hepatocellular carcinoma. Langenbecks Arch Surg (2011) 1.72
Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin. World J Surg (2004) 1.46
Patterns of failure following surgical resection of colorectal cancer liver metastases. Rationale for a multimodal approach. Ann Surg (1987) 1.46
Vascular control during hepatectomy: review of methods and results. World J Surg (2005) 1.36
Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. World J Surg (2007) 1.35
Hilar dissection versus the "glissonean" approach and stapling of the pedicle for major hepatectomies: a prospective, randomized trial. Ann Surg (2003) 1.20
Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice? World J Surg (2010) 1.17
Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan. Liver Cancer (2015) 1.12
Liver resection without total vascular exclusion: hazardous or beneficial? An analysis of our experience. Ann Surg (2001) 1.11
Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World J Surg (2008) 1.08
Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol (2011) 1.06
Total laparoscopic limited anatomical resection for centrally located hepatocellular carcinoma in cirrhotic liver. Surg Endosc (2012) 1.05
Safe and feasible extrahepatic Glissonean access in laparoscopic anatomical liver resection. Surg Endosc (2010) 1.04
Intraoperative ultrasonography in open and laparoscopic abdominal surgery: an overview. Surg Endosc (2006) 1.03
Equivalent outcomes after anatomical and non-anatomical resection of small hepatocellular carcinoma in patients with preserved liver function. Dig Dis Sci (2012) 1.02
Ultrasound-guided finger compression in liver subsegmentectomy for hepatocellular carcinoma. Surg Endosc (2003) 1.02
Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma. Ann Surg (1987) 1.01
Relation between hepatic and portal veins in the right paramedian sector: proposal for anatomical reclassification of the liver. World J Surg (2003) 1.01
Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis. Further evaluation of limited hepatic resection. Ann Surg (1989) 1.01
Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. HPB (Oxford) (2012) 0.99
Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol (2004) 0.98
Laparoscopic liver resections for hepatocellular carcinoma. Is it a feasible option for patients with liver cirrhosis? Langenbecks Arch Surg (2008) 0.97
Surgical treatment of hepatocellular carcinoma. Surg Today (2009) 0.97
Total or partial anatomical resection of segment 8 using the ultrasound-guided finger compression technique. HPB (Oxford) (2011) 0.96
Propensity score analysis demonstrated the prognostic advantage of anatomical liver resection in hepatocellular carcinoma. World J Gastroenterol (2014) 0.96
Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size. World J Surg (2015) 0.95
Efficacy of hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma. World J Gastroenterol (2012) 0.95
Hepatic resection using the harmonic scalpel. Surg Today (2000) 0.95
An appraisal of anatomical and limited hepatectomy for regional hepatolithiasis. HPB Surg (2010) 0.93
Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm. World J Surg (2005) 0.93
A new technique of hepatic segmentectomy by selective portal venous occlusion using a balloon catheter through a branch of the superior mesenteric vein. World J Surg (2007) 0.91
Liver metastasis originating from colorectal cancer with macroscopic portal vein tumor thrombosis: a case report and review of the literature. J Med Case Rep (2010) 0.90
A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma. Cancer Chemother Pharmacol (1989) 0.90
Anatomical versus nonanatomical resection of colorectal liver metastases: a meta-analysis. Int J Colorectal Dis (2012) 0.88
Management of hepatocellular carcinoma in Japan. J Gastroenterol (2006) 0.87
Value of lipiodol computed tomography and digital subtraction angiography in the era of helical biphasic computed tomography as preoperative assessment of hepatocellular carcinoma. Ann Surg (2001) 0.86
Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma. World J Surg (2014) 0.86
Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions. Cancer Chemother Pharmacol (1992) 0.86
Diagnostic and therapeutic management of hepatocellular carcinoma. World J Gastroenterol (2015) 0.85
Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience. Semin Intervent Radiol (2008) 0.85
Liver tissue sparing resection using a novel planning tool. Langenbecks Arch Surg (2010) 0.85
Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome. World J Gastroenterol (2014) 0.85
Clinical analysis of anatomical resection for the treatment of hepatocellular carcinoma based on the stratification of liver function. World J Surg (2014) 0.85
Frequency, risk factors and survival associated with an intrasubsegmental recurrence after radiofrequency ablation for hepatocellular carcinoma. PLoS One (2013) 0.84
Does Establishing a Safety Margin Reduce Local Recurrence in Subsegmental Transarterial Chemoembolization for Small Nodular Hepatocellular Carcinomas? Korean J Radiol (2015) 0.83
Combined intraoperative use of contrast-enhanced ultrasonography imaging using a sonazoid and fluorescence navigation system with indocyanine green during anatomical hepatectomy. Langenbecks Arch Surg (2011) 0.83
Ultrasound-guided microwave coagulation assists anatomical hepatic resection. Surg Today (2011) 0.82
Laparoscopic radiofrequency of hepatocellular carcinoma using ultrasound-guided selective intrahepatic vascular occlusion. Surg Endosc (2008) 0.82
Intraoperative abdominal ultrasound. Gut (1990) 0.81
Clinical Impact of Anatomical Liver Resection for Hepatocellular Carcinoma with Pathologically Proven Portal Vein Invasion. World J Surg (2016) 0.81
A hybrid method of laparoscopic-assisted open liver resection through a short upper midline laparotomy can be applied for all types of hepatectomies. Surg Endosc (2013) 0.81
Clinical outcome of small hepatocellular carcinoma after different treatments: a meta-analysis. World J Gastroenterol (2014) 0.81
Clinicopathologic features and risk factors for extrahepatic recurrences of hepatocellular carcinoma after curative resection. World J Surg (2012) 0.81
Accomplishments in 2007 in the management of hepatobiliary cancers. Gastrointest Cancer Res (2008) 0.81
The impact of posthepatectomy liver failure on the recurrence of hepatocellular carcinoma. World J Surg (2014) 0.80
Ultrasound-guided laparoscopic liver resections. Surg Endosc (2014) 0.80
Role of surgical resection for hepatocellular carcinoma based on Japanese clinical guidelines for hepatocellular carcinoma. World J Hepatol (2015) 0.80
Hepatic resection beyond barcelona clinic liver cancer indication: When and how. World J Hepatol (2016) 0.79
Tailoring the area of hepatic resection using inflow and outflow modulation. World J Gastroenterol (2013) 0.79
Could bipolar vessel sealers prevent bile leaks after hepatectomy? Langenbecks Arch Surg (2006) 0.79
Hepatectomy for hepatocellular carcinoma in the era of liver transplantation. World J Gastroenterol (2014) 0.79
Concepts for Liver Segment Classification: Neither Old Ones nor New Ones, but a Comprehensive One. J Clin Imaging Sci (2013) 0.79
Three-dimensional volumetry in 107 normal livers reveals clinically relevant inter-segment variation in size. HPB (Oxford) (2013) 0.78
Surgical treatment of hepatocellular carcinoma: evidence-based outcomes. World J Gastroenterol (2008) 0.78
Practical usefulness of ultrasonic surgical aspirator with argon beam coagulation for hepatic parenchymal transection. World J Surg (2005) 0.78
Isolated paracaval subsegmentectomy of the caudate lobe of the liver. Langenbecks Arch Surg (2003) 0.78
Are Tumor Exposure and Anatomical Resection Antithetical during Surgery for Hepatocellular Carcinoma? A Critical Review. Liver Cancer (2012) 0.77
Surgical options for initially unresectable colorectal liver metastases. HPB Surg (2012) 0.77
Precise anatomical resection of the ventral part of Segment VIII. Int J Surg Case Rep (2014) 0.77
Liver segments: an anatomical rationale for explaining inconsistencies with Couinaud's eight-segment concept. Surg Radiol Anat (2010) 0.77
Combined ultrasonic aspiration and saline-linked radiofrequency precoagulation: a step toward bloodless liver resection without the need of liver inflow occlusion: analysis of 313 consecutive patients. World J Surg Oncol (2014) 0.77
Anatomic wide hepatectomy for treatment of hepatocellular carcinoma. J Cancer Res Clin Oncol (2007) 0.76
Clinical factors that affect the outcomes after anatomical versus non-anatomical resection for hepatocellular carcinoma. Surg Today (2016) 0.76
Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation. World J Surg (2016) 0.76
Clinicopathological features of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease. Langenbecks Arch Surg (2015) 0.76
mPGES-1 expression in non-cancerous liver tissue impacts on postoperative recurrence of HCC. World J Gastroenterol (2010) 0.76
Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors. Langenbecks Arch Surg (2010) 0.76
Ramification of Glisson's sheath peripheral branches and clinical implications in the era of local ablation therapy. Surg Radiol Anat (2010) 0.76
Elastography for hepato-biliary-pancreatic surgery. Surg Today (2013) 0.76
Clinical application of indocyanine green-fluorescence imaging during hepatectomy. Hepatobiliary Surg Nutr (2016) 0.75
Anatomical resection of hepatocellular carcinoma: A critical review of the procedure and its benefits on survival. World J Gastroenterol (2017) 0.75
Portal triad clamping versus other methods of vascular control in liver resection: a systematic review and meta-analysis. HPB (Oxford) (2012) 0.75
Current Technical Issues for Surgery of Primary Liver Cancer. Liver Cancer (2016) 0.75
Comparison of Anatomical and Nonanatomical Hepatectomy for Colorectal Liver Metastasis: A Meta-Analysis of 5207 Patients. Sci Rep (2016) 0.75
Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma. Exp Ther Med (2016) 0.75
Survival Benefits of Small Anatomical Resection of the Liver for Patients with Hepatocellular Carcinoma and Impaired Liver Function, Based on New-Era Imaging Studies. J Cancer (2016) 0.75
Ultrasound-guided liver resection: Early experience in a district general hospital. J Ultrasound (2008) 0.75
Management before hepatectomy for hepatocellular carcinoma with cirrhosis. World J Hepatol (2015) 0.75
Clinical Anatomy of the Liver: Review of the 19th Meeting of the Japanese Research Society of Clinical Anatomy. Liver Cancer (2016) 0.75
Superselective intra-arterial hepatic injection of indocyanine green (ICG) for fluorescence image-guided segmental positive staining: experimental proof of the concept. Surg Endosc (2016) 0.75
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med (2000) 13.13
Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer (1985) 7.67
Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol (1999) 7.60
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev (2001) 7.60
Complete genome sequence of an aerobic hyper-thermophilic crenarchaeon, Aeropyrum pernix K1. DNA Res (1999) 7.39
Entrainment of the circadian clock in the liver by feeding. Science (2001) 7.09
Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science (2000) 4.94
Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol (1970) 4.85
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet (2000) 4.60
Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery (1990) 3.93
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology (2000) 3.42
Calculation of child and adult standard liver volume for liver transplantation. Hepatology (1995) 3.33
Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology (1997) 3.28
Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet (1993) 3.28
Staining methods of Australia antigen in paraffin section--detection of cytoplasmic inclusion bodies. Jpn J Exp Med (1974) 3.08
Surgery for small liver cancers. Semin Surg Oncol (1993) 3.00
Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg (2000) 2.92
Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg (1999) 2.86
Complete nucleotide sequence and genetic organization of Aichi virus, a distinct member of the Picornaviridae associated with acute gastroenteritis in humans. J Virol (1998) 2.85
Contrast-enhanced ultrasonography during liver surgery. Br J Surg (2004) 2.71
A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol (2000) 2.70
No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg (1999) 2.47
Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery (1994) 2.45
The molecular epidemiology of HIV in Asia. AIDS (1994) 2.37
Recurrence of hepatocellular carcinoma after surgery. Br J Surg (1996) 2.27
Randomized comparison of ultrasonic vs clamp transection of the liver. Arch Surg (2001) 2.25
Are left-sided gallbladders really located on the left side? Ann Surg (1997) 2.24
Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg (1999) 2.24
Purification and characterization of DNA polymerase II from the yeast Saccharomyces cerevisiae. Identification of the catalytic core and a possible holoenzyme form of the enzyme. J Biol Chem (1990) 2.06
Aggravation of subclinical diabetes insipidus during pregnancy. N Engl J Med (1991) 2.03
Criteria for safe hepatic resection. Am J Surg (1995) 2.03
How should polypoid lesions of the gallbladder be treated in the era of laparoscopic cholecystectomy? Surgery (1995) 2.02
Chronic jet-lag increases mortality in aged mice. Curr Biol (2006) 2.01
Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol (2000) 1.99
Splenectomy in patients with hepatocellular carcinoma and hypersplenism. J Am Coll Surg (2000) 1.99
Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet (1987) 1.98
Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology (1998) 1.97
Expression of normal and transforming H-ras genes in Escherichia coli and purification of their encoded p21 proteins. Proc Natl Acad Sci U S A (1984) 1.94
CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol Cell Biol (1994) 1.92
Identification of hypoxia-inducible factor 1 ancillary sequence and its function in vascular endothelial growth factor gene induction by hypoxia and nitric oxide. J Biol Chem (2000) 1.86
Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet (1990) 1.75
EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J Immunol (2001) 1.75
Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology (1999) 1.73
Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology (1987) 1.73
Living related liver transplantation in adults. Ann Surg (1998) 1.72
Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol (2000) 1.71
Chronic subdural hematoma, as an initial manifestation of glutaric aciduria type-1. Brain Dev (1993) 1.70
Direct activation of mitochondrial K(ATP) channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc Res (2001) 1.69
Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci (1995) 1.68
A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto) Ann Neurol (2000) 1.65
Preoperative portal vein embolization: an audit of 84 patients. Hepatology (1999) 1.64
Action of interferon: kinetics and differential effects on viral functions. J Virol (1970) 1.63
Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology (1993) 1.62
A selenium-containing hydrogenase from Methanococcus vannielii. Identification of the selenium moiety as a selenocysteine residue. J Biol Chem (1982) 1.62
Cloning, functional analysis and cell localization of a kidney proximal tubule water transporter homologous to CHIP28. J Cell Biol (1993) 1.60
Preoperative drainage using a transanal tube enables elective laparoscopic colectomy for obstructive distal colorectal cancer. Endoscopy (2013) 1.60
Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer (1987) 1.60
Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg (1989) 1.59
Transcellular water transport in lung alveolar epithelium through mercury-sensitive water channels. Proc Natl Acad Sci U S A (1994) 1.59
Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg (2001) 1.58
Guanosine nucleotide binding by highly purified Ha-ras-encoded p21 protein produced in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.55
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut (2005) 1.54
Gangliocytic paraganglioma of the papilla of Vater with regional lymph node metastasis. Am J Gastroenterol (1992) 1.52
A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration. Neurology (1999) 1.52
Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury. Gene Ther (1999) 1.51
Congestion of right liver graft in living donor liver transplantation. Transplantation (2001) 1.51
Comparisons of intraosseous graft healing between the doubled flexor tendon graft and the bone-patellar tendon-bone graft in anterior cruciate ligament reconstruction. Arthroscopy (2001) 1.51
Serous cystadenoma of the pancreas with invasive growth: benign or malignant? Am J Gastroenterol (1998) 1.49
Inflammatory pseudotumors of the liver: prevalence and clinical impact in surgical patients. Hepatogastroenterology (2001) 1.49
The use of operative ultrasound as an aid to liver resection in patients with hepatocellular carcinoma. World J Surg (1987) 1.49
Cloning of a water channel homolog expressed in brain meningeal cells and kidney collecting duct that functions as a stilbene-sensitive glycerol transporter. J Biol Chem (1994) 1.47
Successful living-related partial liver transplantation to an adult patient. Lancet (1994) 1.47
An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun (1998) 1.47
Pharmacokinetics, toxicokinetics, distribution, metabolism and excretion of linezolid in mouse, rat and dog. Xenobiotica (2002) 1.47
The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am (2000) 1.46
Arterial ketone body ratio in liver surgery. Hepatology (1994) 1.45
The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR Am J Roentgenol (1990) 1.45
Immunohistochemical localization of prostaglandin EP3 receptor in the rat nervous system. J Comp Neurol (2000) 1.44
Cryptococcosis after living donor liver transplantation: report of three cases. Transpl Infect Dis (2005) 1.44
Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin. Br J Dermatol (2004) 1.44
The complete nucleotide sequence of a variant of Coxsackievirus A24, an agent causing acute hemorrhagic conjunctivitis. Virus Genes (1992) 1.44
Is the food-entrainable circadian oscillator in the digestive system? Genes Brain Behav (2003) 1.44
Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder. Hum Pathol (2001) 1.43
Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene (2006) 1.43
Probiotics and safety. Am J Clin Nutr (2001) 1.42
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest (1999) 1.42
A large outbreak of acute gastroenteritis associated with astrovirus among students and teachers in Osaka, Japan. J Infect Dis (1994) 1.42